Literature DB >> 13766082

Quantitative observations on antinuclear factors in systemic lupus erythematosus.

E MANDEMA, V E POLLAK, R M KARK, J REZAIAN.   

Abstract

Entities:  

Keywords:  CELL NUCLEUS; LUPUS ERYTHEMATOSUS/immunology

Mesh：

Substances：

Year:  1961        PMID： 13766082

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  9 in total

1.  A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

Authors:  R L NIENHUIS; E MANDEMA
Journal:  Ann Rheum Dis       Date:  1964-07       Impact factor: 19.103

2.  POPULATION STUDIES OF RHEUMATIC DISEASES ON A COSTAL ISLAND. II. ANTINUCLEAR FACTORS AND ANTITHYROID ANTIBODIES.

Authors:  R L NIENHUIS; E MANDEMA; A JANSZ
Journal:  Ann Rheum Dis       Date:  1963-11       Impact factor: 19.103

3.  COMPARATIVE STUDY FOR THE DETECTION OF ANTINUCLEAR FACTORS WITH THE FLUORESCENT ANTIBODY TECHNIQUE.

Authors:  W HIJMANS; H R SCHUIT; E MANDEMA; R L NIENHUIS; T E FELTKAMP; E J HOLBOROW; G D JOHNSON
Journal:  Ann Rheum Dis       Date:  1964-01       Impact factor: 19.103

4.  [On the problem of immunobiologic relations between lupus erythematosus disseminatus and progressive scleroderma].

Authors:  H Talke; H Holzmann
Journal:  Arch Klin Exp Dermatol       Date:  1967

5.  [Studies on the importance of the fluorescence-antiglobulin test and the antiglobulin-consumption test for the demonstration of antinuclear serum factors].

Authors:  C Mueller-Eckhardt; K Schmidt; W Becker
Journal:  Blut       Date:  1968-07

6.  [Immunopathological examinations in lupus erythematodes disseminatus (subacutus and acutus)].

Authors:  T Chorzelski; S Jablońska; M Blaszczyk
Journal:  Arch Klin Exp Dermatol       Date:  1968

7.  Lymphocytotoxic antibodies in patients with systemic lupus erythematosus.

Authors:  B S Ooi; A R Orlina; A J Pesce; N Mendoza; L Masaitis; V E Pollak
Journal:  Clin Exp Immunol       Date:  1974-06       Impact factor: 4.330

8.  [Fluorescence microscopic demonstration of antinuclear factors in lupus erythematosus and related diseases].

Authors:  K Havemann; P Arend
Journal:  Klin Wochenschr       Date:  1966-01-01

Review 9.  Insights into the study and origin of the citrullinome in rheumatoid arthritis.

Authors:  Justyna Fert-Bober; Erika Darrah; Felipe Andrade
Journal:  Immunol Rev       Date:  2019-12-25       Impact factor: 12.988
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.